Sreenivasu MUDUMBA,Philippe JM DOR,Thierry NIVAGGIOLI,David A. WEBER,Sidiq FAROOQ
申请号：
US15611701
公开号：
US20170266109A1
申请日:
2017.06.01
申请国别(地区):
US
年份:
2017
代理人:
摘要：
Described herein are liquid rapamycin formulations. Described herein are methods of treating or preventing diseases or conditions, such as choroidal neovascularization, wet AMD and dry AMD, and preventing transition of dry AMD to wet AMD, using the liquid rapamycin formulations described herein.
